RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin.
Mi J, Zhang X, Rabbani ZN, Liu Y, Reddy SK, Su Z, Salahuddin FK, Viles K, Giangrande PH, Dewhirst MW, Sullenger BA, Kontos CD, Clary BM.
Mi J, et al. Among authors: sullenger ba.
Mol Ther. 2008 Jan;16(1):66-73. doi: 10.1038/sj.mt.6300320. Epub 2007 Oct 2.
Mol Ther. 2008.
PMID: 17912235
Free article.